Thermolability of factor VIII in donor fresh frozen blood plasma

Author:

Lemondzhava V. N.1ORCID,Chechetkin A. V.2ORCID,Gudkov A. G.3ORCID,Leushin V. Yu.1ORCID,Kasianov A. D.2ORCID,Kiseleva E. A.2ORCID

Affiliation:

1. Hyperion Ltd

2. Russian Research Institute of Hematology and Transfusiology

3. Bauman Moscow State Technical University (National Research University of Technology)

Abstract

A criterion of the quality of fresh frozen blood plasma (FFP) is the activity of clotting factor VIII (FVIII).Aim — to identify technological barriers in the study of FVIII thermolability and to describe the requirements for experiments, providing new knowledge about the thermolability of this factor.Basic information. An analysis of domestic and foreign publications devoted to the study of the mechanisms responsible for reducing the value of FVIII activity in donor blood plasma from the moment of donation to the moment of transfusion was carried out. Data on the decrease in FVIII activity at various stages of work with blood plasma are presented. An analysis of methods for preparing samples for studying changes in the values of FVIII in donor blood plasma was performed. The existence of contradictory conclusions about the infl uence on the change in FVIII at the thawing stage of various values of the effects on FFP and poor knowledge of the change in the indicator at the stage of heating to the transfusion temperature after the end of the phase transition in the samples was established. The fundamental differences in the methods of preparing and conducting experiments in previous works are determined. Methods for increasing the reliability of experimental results for studying the thermal lability of FVIII are proposed.

Publisher

National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation

Subject

Hematology

Reference92 articles.

1. Zhiburt E.B. Transfusiology: textbook. Saint Petersburg: Piter; 2002: 327 p. (in Russian).

2. Hematology: A guide for doctors. Ed. N.N. Mamaev, S.I. Ryabov. Saint Petersburg: SpetsLit; 2008: 543 p. (in Russian).

3. Dolgov V.V., Svirin P.V. Laboratory diagnostics of hemostasis disorders. Moscow – Tver: LLC “Publishing house Triada”; 2005: 227 p. (in Russian).

4. Tiede A. Half-life extended factor VIII for the treatment of hemophilia A. Journal of Thrombosis and Haemostasis. 2015; 13(Suppl 1): 176–9. DOI: 10.1111/jth.12929.

5. Bjorkman S., Folkesson A., Jonsson S. Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years: A population analysis based on 50 patients with long-term prophylactic treatment for haemophilia A. Eur J Clin Pharmacol. 2009; 65(10): 989–98. DOI: 10.1007/s00228-009-0676-x.

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3